These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Antiviral agents for hepatitis B. Gerin JL Hepatology; 1991 Jul; 14(1):198-9. PubMed ID: 2066069 [No Abstract] [Full Text] [Related]
7. Alteration of the dismal natural history of fibrosing cholestatic hepatitis secondary to hepatitis B virus with the use of lamivudine. Al Faraidy K; Yoshida EM; Davis JE; Vartanian RK; Anderson FH; Steinbrecher UP Transplantation; 1997 Sep; 64(6):926-8. PubMed ID: 9326423 [TBL] [Abstract][Full Text] [Related]
12. Navigating the maze of hepatitis B treatments. Lok AS Gastroenterology; 2007 Apr; 132(4):1586-94. PubMed ID: 17408643 [No Abstract] [Full Text] [Related]
13. Successful control of subfulminant hepatitis related to lamivudine-resistant hepatitis B virus in an HIV-infected patient. Thabut D; Thibault V; Benhamou Y; Bernard B; Aubron-Olivier C; Poynard T; Di Martino V AIDS; 2001 Dec; 15(18):2463-4. PubMed ID: 11774835 [No Abstract] [Full Text] [Related]
14. In vitro models for studying hepatitis B virus drug resistance. Zoulim F Semin Liver Dis; 2006 May; 26(2):171-80. PubMed ID: 16673295 [TBL] [Abstract][Full Text] [Related]
15. Recurrence of hepatitis B in liver transplants treated with antiviral therapy. Marzano A; Debernardi-Venon W; Smedile A; Brunetto MR; Torrani Cerenzia MR; Actis GC; Zamboni F; Ghisetti V; Piantino P; David E; Salizzoni M; Rizzetto M Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):77-81. PubMed ID: 9615271 [TBL] [Abstract][Full Text] [Related]
16. Lamivudine: a new strategy to suppress HBV replication in the pretransplant setting. Macedo G; Maia JC; Gomes A; Beleza M; Teixeira A; Ribeiro A Transplant Proc; 2000 Dec; 32(8):2642. PubMed ID: 11134737 [No Abstract] [Full Text] [Related]
17. Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients. Benhamou Y; Dohin E; Lunel-Fabiani F; Poynard T; Huraux JM; Katlama C; Opolon P; Gentilini M Lancet; 1995 Feb; 345(8946):396-7. PubMed ID: 7845151 [No Abstract] [Full Text] [Related]
18. Management of special patient groups with hepatitis B virus infection: The EASL 2017 Clinical Practice Guidelines. Idilman R Turk J Gastroenterol; 2017 Nov; 28(6):518-521. PubMed ID: 29082891 [TBL] [Abstract][Full Text] [Related]
19. Oral ganciclovir for treatment of lamivudine-resistant hepatitis B virus infection: a pilot study. Bozkaya H; Yurdaydin C; Bozdayi AM; Erkan O; Karayalcin S; Uzunalimoglu O Clin Infect Dis; 2002 Oct; 35(8):960-5. PubMed ID: 12355383 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus (HBV) DNA assays (methods and practical use) and viral kinetics. Pawlotsky JM J Hepatol; 2003; 39 Suppl 1():S31-5. PubMed ID: 14708675 [No Abstract] [Full Text] [Related] [Next] [New Search]